Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects (Q39097112)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 December 2016
edit
Language Label Description Also known as
English
Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects
scientific article published on 13 December 2016

    Statements

    Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects (English)
    Takahiro Takase
    Akinobu Nakamura
    Hideaki Miyoshi
    Chiho Yamamoto
    Tatsuya Atsumi
    13 December 2016
    363-367

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit